TSN
Tyson Foods, Inc.
(NYSE: TSN)
Balfour Capital Group has issued a buy recommendation
for Tyson Foods, Inc. (TSN) on August 11th, 2025
Tyson Foods is a global, multi-protein food company and “recognized leader in protein, ” operating four segments—Beef, Pork, Chicken (vertically integrated), and Prepared Foods (brands include Tyson, Jimmy Dean, Hillshire Farm, Ball Park, Wright, Aidells, ibp).
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $57.04 on August 11, 2025.
- Our designated price target stands at $89.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
2025 Q3 EARNING REPORT
A Q3 report evaluates company financials for investors.
Balfour Capital Group wants to clarify that our recommendation to Buy Tyson Foods, Inc. (NYSE: TSN) is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
COIN
Coinbase Global, Inc.
(NASDAQ: COIN)
Balfour Capital Group Researched Coinbase Global, Inc. (COIN) on August 8th, 2025.
Coinbase operates a crypto-native financial platform spanning retail and institutional trading (spot & derivatives), custody (Prime/Trust), staking, stablecoin economics (USDC), payments, and developer infra (Base L2, wallets, APIs). Its stated mission is to “increase economic freedom” by bringing the financial system on-chain.
Post Recommendation Price Trend Chart
- We have established a Sell recommendation at $310,79 on August 8th, 2025.
- Our designated price target stands at $230.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
2025 Q2 EARNING REPORT
A Q2 report evaluates company financials for investors
Balfour Capital Group wants to clarify that our recommendation to Sell Coinbase Global, Inc. (NASDAQ: COIN) is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
HOLX
Hologic, Inc.
(NASDAQ: HOLX)
Balfour Capital Group has issued a buy recommendation
for Hologic, Inc. (HOLX) on August 8th, 2025
Hologic is a women’s-health–focused med-tech company with three core franchises: Diagnostics (molecular/Pap/sexually transmitted infection assays, Panther systems), Breast Health (3D mammography/tomosynthesis, biopsy), and GYN Surgical (MyoSure, NovaSure).
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $67.93 on August 8, 2025.
- Our designated price target stands at $100.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
View More
2025 Q3 EARNING REPORT
A Q3 report evaluates company financials for investors.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
Balfour Capital Group wants to clarify that our recommendation to Buy Hologic, Inc. (NASDAQ: HOLX) is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
ALAB
Astera Labs, Inc.
(NASDAQ: ALAB)
Balfour Capital Group has issued a buy recommendation
for Astera Labs, Inc. (ALAB) on August 8th, 2025
Astera Labs is a fabless semiconductor company focused on high-speed connectivity for AI and cloud data centers (PCIe/CXL retimers and modules, Ethernet smart-cable modules, and rack-scale “Scorpio” fabric switches). Product families include Aries, Taurus, Leo, and Scorpio.
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $170.89 on August 8, 2025.
- Our designated price target stands at $230.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
2025 Q2 EARNING REPORT
A Q2 report evaluates company financials for investors.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
Balfour Capital Group wants to clarify that our recommendation to Buy Astera Labs, Inc. (NASDAQ: ALAB) is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
TEVA
Teva Pharmaceutical Industries Ltd.
(NYSE: TEVA)
Balfour Capital Group has issued a buy recommendation
for Teva Pharmaceutical Industries Ltd. (TEVA) on August 5th, 2025
Teva Pharmaceutical Industries Ltd., headquartered in Tel Aviv, is the largest generic drug manufacturer in the world. While best known for generics, its portfolio spans specialty branded pharmaceuticals (e.g. Austedo, Ajovy, Copaxone, Uzedy), APIs, contract manufacturing, and out‑licensing platforms. The company operates in three geographic segments—North America, Europe, and International Markets—with manufacturing facilities across Israel, North America, Europe, Australia, and South America.
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $15.69 on August 5, 2025.
- Our designated price target stands at $28.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
View More
2025 Q2 EARNING REPORT
A Q2 report evaluates company financials for investors.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
Balfour Capital Group wants to clarify that our recommendation to Buy Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
TXT
Textron Inc.
(NYSE: TXT)
Balfour Capital Group has issued a buy recommendation
for Textron Inc. (TXT) on July 31st, 2025
Textron Inc. is an American industrial conglomerate headquartered in Providence, Rhode Island. It operates across six core segments: Textron Aviation (Beechcraft, Cessna, Pipistrel), Bell (helicopters, tiltrotors), Textron Systems (uncrewed systems, marine/land vehicles, simulation), Industrial (including Arctic Cat and Kautex plastic systems), Textron eAviation, and its Finance arm.
It designs, manufactures, and services specialty aircraft, helicopters, defense systems, and industrial tools for both commercial and military clients.
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $78.05 on July 31, 2025.
- Our designated price target stands at $125.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
2025 Q2 EARNING REPORT
A Q2 report evaluates company financials for investors.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
Balfour Capital Group wants to clarify that our recommendation to Buy Textron Inc. (NYSE: TXT) is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
GWW
W.W. Grainger, Inc.
(NYSE: GWW)
Balfour Capital Group has issued a buy recommendation
for W.W. Grainger, Inc. (GWW) on July 31st, 2025
W. W. Grainger, Inc. is a leading business‑to‑business distributor of maintenance, repair, and operations (MRO) supplies. Founded in 1927 and based in Lake Forest, Illinois, it serves over 4.5 million customers globally through a network of branches, distribution centers, online platforms (Grainger.com, Zoro, MonotaRO), and inventory management services. The product range includes safety equipment, fasteners, tools, pumps/plumbing, material handling, and technical support services.
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $1,042.67 on July 31, 2025.
- Our designated price target stands at $1,300.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
2025 Q1 EARNING REPORT
A Q1 report evaluates company financials for investors.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
Balfour Capital Group wants to clarify that our recommendation to Buy W.W. Grainger, Inc. (NYSE: GWW) is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
WHR
Whirlpool Corporation
(NYSE: WHR)
Balfour Capital Group Researched Whirlpool Corporation (WHR) on July 17th, 2025.
Whirlpool Corporation is a leading U.S. -based manufacturer and marketer of home and kitchen appliances — including refrigerators, washers, dryers, dishwashers, microwaves, and small domestic units — under brands like Whirlpool, KitchenAid, Maytag, JennAir, Amana, Brastemp, Consul, InSinkErator, Gladiator, and more. Founded in 1911 and headquartered in Benton Harbor, Michigan, the company operates globally with ~44,000 employees, generating approximately US $16.6 billion in revenue in 2024 (≈ $19.5 b in 2023).
Post Recommendation Price Trend Chart
- We have established a Sell recommendation at $96.16 on July 17th, 2025.
- Our designated price target stands at $70.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
2025 Q1 EARNING REPORT
A Q1 report evaluates company financials for investors
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
Balfour Capital Group wants to clarify that our recommendation to Sell Whirlpool Corporation (NYSE: WHR) is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
NFG
National Fuel Gas Company
(NYSE: NFG)
Balfour Capital Group has issued a buy recommendation
for National Fuel Gas Company (NFG) on July 17th, 2025
NFG is a diversified, integrated natural gas company operating through four segments:
- Exploration & Production (Seneca Resources) – drills in Appalachia, focusing on Marcellus and Utica shales.
- Pipeline & Storage – owns ~2,800 miles of interstate pipelines and 31 storage fields in NY and PA.
- Gathering – builds and operates gathering systems in Appalachia.
- Utility – distributes gas to ~755,000 residential and commercial customers in western NY and northwestern PA. Headquartered in Williamsville, NY, founded in 1902, with ~2,300 employees.
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $88.31 on July 17, 2025.
- Our designated price target stands at $115.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
2025 Q2 EARNING REPORT
A Q2 report evaluates company financials for investors.
Balfour Capital Group wants to clarify that our recommendation to Buy National Fuel Gas Company (NYSE: NFG) is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
WMB
The Williams Companies, Inc.
(NYSE: WMB)
Balfour Capital Group has issued a buy recommendation
for The Williams Companies, Inc. (WMB) on July 17th, 2025
Williams is a U.S. -based energy infrastructure company, primarily focused on natural gas processing, transportation, and storage, along with gas & NGL marketing and handling some crude oil assets. They operate major pipeline networks like Transco, Northwest, and MountainWest and handle roughly one-third of U.S. natural gas volume daily.
Post Recommendation Price Trend Chart
- We have established a Buy recommendation at $58.48 on July 17, 2025.
- Our designated price target stands at $75.00
Analysts Research
With steadfast dedication to thorough research, Balfour Capital Group engages with esteemed analysts and companies, evident below, to amplify and elevate our proficiency. This collaborative approach enriches our findings, granting readers and researchers a profound comprehension of the rationale behind our recommendations and research objectives.
View More
ARGUS QUANTITATIVE
Argus Quantitative analyzes energy, commodities, and finance with data analytics.
View More
ARGUS ANALYST
Argus Analyst Notes offers timely investment recommendations, insights.
View More
THOMSON REUTERS
Thomson Reuters delivers global financial, legal, and business information to professionals.
View More
2025 Q1 EARNING REPORT
A Q1 report evaluates company financials for investors.
Balfour Capital Group wants to clarify that our recommendation to Buy The Williams Companies, Inc. (NYSE: WMB) is based on thorough research conducted by our dedicated teams.
We invest significant time and resources in analyzing market trends, financial data, and industry insights to provide well-informed guidance.
However, it is important to note that our recommendation does not guarantee any specific financial outcomes. The decision to act on our recommendation should be made at your discretion. Please be aware that investments carry inherent risks, and the value of investments can fluctuate, potentially resulting in financial loss.
*THIS INFORMATION IS PROVIDED FOR COMMERCIAL AND INDICATIVE PURPOSES ONLY AND MAY DIFFER FROM REALITY. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. TRADING WITH LEVERAGE INVOLVES A SUBSTANTIAL RISK OF LOSS AND MAY NOT BE SUITABLE FOR ALL INVESTORS.*
